Chloe Kelly overcame a major ACL injury to score the winner in this summer’s Euros. She overcame something else too: what she described as the crushing “negativity” around her ACL injury that saw her struggling mentally during her recovery. Nick London shares his take on Chloe’s situation.
Which knee brace should you buy? And are there some you should avoid? Jim Newman explains.
We’ve seen growing interest in orthobiologic treatments in recent years. In many cases, the chance for relief from joint pain, and even the ‘promise’ of a ‘cure’ for osteoarthritis has led many to explore these injectable remedy routes. But do they work?
And is it something you should be worried about? Jim Newman explains.
As a new study finds little value in arthroscopies in degenerative knee conditions (i.e. arthritis), is there ever a case for this keyhole procedure?
It’s the sort of ‘belt and braces’ treatment that can prove particularly valuable for patients planning a return to sports with a high risk of retearing the ACL. But does anterolateral ligament reconstruction lead to greater risk? Jim Newman reviews the evidence.
On 11-13 May 2022, the European Knee Society (EKS) is meeting at Gleneagles in Scotland for its latest members-only session. After a Covid-enforced two-year hiatus, Yorkshire Knee Clinic’s Nick London is delighted to be back.
A few weeks ago, the Daily Mail published an article headlined ‘NHS hospitals are told should NOT perform routine ops on Covid patients until SEVEN WEEKS after they’ve beaten the virus – despite massive backlog.’ Jim Newman would like to take issue with it…
Some knee dislocations are rare, obvious and extremely serious. Others are far less serious but far more common.
Is there anything to the recent reports that statins can cause knee pain?
Last year, a (much disputed) paper generated headlines by suggesting there was a lack of evidence for some orthopaedic surgery. Now, a new paper suggests quite the contrary.
Knee replacement waiting lists are one of the more headline-grabbing challenges for the NHS to address as we exit the pandemic. But a less well publicised problem is contributing to those numbers: the training of orthopaedic surgeons.